Literature DB >> 6390774

Management of pulmonary aspergilloma in the presence of active tuberculosis.

A O Adeyemo, E O Odelowo, D I Makanjuola.   

Abstract

Eleven cases of pulmonary aspergilloma complicating active cavitating pulmonary tuberculosis are reviewed. Nine of the 10 patients who had combined medical (antituberculosis drugs) and surgical treatment were cured of their disease; one patient, who had bilateral multiple aspergillomas, died from massive haemoptysis after resection of one of the affected lobes. The only medically treated patient who refused surgery had fatal haemoptysis at home. Pulmonary resection is recommended for patients who are fit for operation whenever the diagnosis of aspergilloma is made because most published reports indicate that only a few patients benefit from drug treatment alone.

Entities:  

Mesh:

Year:  1984        PMID: 6390774      PMCID: PMC459938          DOI: 10.1136/thx.39.11.862

Source DB:  PubMed          Journal:  Thorax        ISSN: 0040-6376            Impact factor:   9.139


  30 in total

1.  Treatment of bronchopulmonary aspergillosis with observations on the use of natamycin.

Authors:  A H Henderson; J E Pearson
Journal:  Thorax       Date:  1968-09       Impact factor: 9.139

2.  Sarcoidosis and aspergilloma.

Authors:  H L Israel; A Ostrow
Journal:  Am J Med       Date:  1969-08       Impact factor: 4.965

Review 3.  Mycotic infections of interest to thoracic surgeons.

Authors:  T Takaro
Journal:  Ann Thorac Surg       Date:  1967-01       Impact factor: 4.330

4.  A pharmacologic guide to the clinical use of amphotericin B.

Authors:  D D Bindschadler; J E Bennett
Journal:  J Infect Dis       Date:  1969-10       Impact factor: 5.226

5.  Empyema treated with neomycin irrigation and closed-chest drainage.

Authors:  R A Dieter; R Pifarré; W E Neville; M Magno; M Jasuja
Journal:  J Thorac Cardiovasc Surg       Date:  1970-04       Impact factor: 5.209

6.  Pulmonary aspergillosis in sanatoriums in the south central United States. A national communicable disease center cooperative mycoses study.

Authors:  J D Parker; G A Sarosi; I L Doto; F E Tosh
Journal:  Am Rev Respir Dis       Date:  1970-04

7.  Surgery for pulmonary aspergillosis.

Authors:  J W Kilman; C Ahn; N C Andrews; K Klassen
Journal:  J Thorac Cardiovasc Surg       Date:  1969-05       Impact factor: 5.209

8.  Fungal flora of the normal human small and large intestine.

Authors:  R Cohen; F J Roth; E Delgado; D G Ahearn; M H Kalser
Journal:  N Engl J Med       Date:  1969-03-20       Impact factor: 91.245

9.  Radiology of the aspergilloma.

Authors:  A Irwin
Journal:  Clin Radiol       Date:  1967-10       Impact factor: 2.350

10.  Significance and interpretation of laboratory tests in pulmonary aspergillosis.

Authors:  M P English; A H Henderson
Journal:  J Clin Pathol       Date:  1967-11       Impact factor: 3.411

View more
  5 in total

1.  Surgical diagnosis of bronchopulmonary disease in Nigerians: the role of mediastinal biopsy.

Authors:  E O Odelowo; A S Anjorin
Journal:  J Natl Med Assoc       Date:  1991-12       Impact factor: 1.798

Review 2.  Pathogen-pathogen interaction: a syndemic model of complex biosocial processes in disease.

Authors:  Merrill Singer
Journal:  Virulence       Date:  2010 Jan-Feb       Impact factor: 5.882

3.  Management of post-tuberculous complex aspergilloma of the lung: role of surgical resection.

Authors:  S A al-Majed; M Ashour; F A el-Kassimi; I Joharjy; A al-Wazzan; M S al-Hajjaj; R Vijay
Journal:  Thorax       Date:  1990-11       Impact factor: 9.139

4.  A Histomorphological Pattern Analysis of Pulmonary Tuberculosis in Lung Autopsy and Surgically Resected Specimens.

Authors:  Mamta Gupta; Flora D Lobo; Deepa Sowkur Anandarama Adiga; Abhishek Gupta
Journal:  Patholog Res Int       Date:  2016-03-21

5.  Clinical manifestations, associated risk factors and treatment outcomes of Chronic Pulmonary Aspergillosis (CPA): Experiences from a tertiary care hospital in Lahore, Pakistan.

Authors:  Waqas Akram; Muhammad Bilal Ejaz; Tauqeer Hussain Mallhi; Syed Azhar Bin Syed Sulaiman; Amer Hayat Khan
Journal:  PLoS One       Date:  2021-11-12       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.